n-methyladenosine has been researched along with Neoplasms in 101 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (0.99) | 29.6817 |
2010's | 30 (29.70) | 24.3611 |
2020's | 70 (69.31) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Belaydi, O; Chen, J; Chen, M; Gong, G; Hu, J; Li, H; Liu, P; Ma, H; Ou, Z; Qiu, D; Quan, C; Ren, W; Sun, Y; Yi, Z; Yu, A; Zu, X | 1 |
Cheng, M; Ding, C; Flavell, RA; Li, HB; Peng, H; Song, H; Song, J; Sun, R; Tian, S; Tian, Z; Wang, T; Wei, H; Zheng, M; Zhu, S | 1 |
Ashraf, MU; Bae, YS; Kang, MH; Kumar, S; Kumar, V; Mani, I; Sarthi, P | 1 |
Chen, J; Du, Y; Huang, Z; Liu, X; Qin, H; Zhao, Y | 1 |
Chen, J; Chen, Z; Li, Y; Lin, J; Lin, Z; Shao, W; Tao, B; Yi, C; Zhang, B | 1 |
Guo, L; Huang, L; Shi, Y; Yang, H; Zhang, J; Zhou, C | 1 |
An, Y; Duan, H | 1 |
Chen, P; Chen, Y; Han, X; Hu, J | 1 |
Cai, Z; Cao, W; He, J; Hou, Y; Liu, Y; Qu, J; Yan, H; Zhang, E | 1 |
David, A; Relier, S; Rivals, E | 1 |
Hu, D; Li, H; Liu, J; Liu, L; Shao, W; Wang, Y; Yang, S; Zhang, J; Zhong, J | 1 |
Cai, J; Cai, M; Li, A; Li, J; Lv, Y; Ma, Q; Wu, W; Zhao, W | 1 |
Dong, W; Jiang, H; Li, Y; Liu, Y | 1 |
Chen, S; Deng, H; Duan, Y; Li, G; Li, M; Wei, J; Xiong, W; Xue, C; Zhan, Y; Zheng, L; Zhou, M | 1 |
Bao, Z; Chu, Q; Jiang, S; Li, L; Lu, J; Su, Y; Xue, C; Zheng, Q | 1 |
He, A; Jia, Y; Kong, G; Liu, R | 1 |
Cao, Y; Gou, Y; Jiao, N; Li, Z; Liang, Z; Tan, J; Wang, H; Yu, Y; Zhang, Z | 1 |
Lin, H; Long, F; Wang, P; Wang, T; Wang, Y | 1 |
Hu, C; Ji, D; Jiang, W; Li, Y; Liu, J; Liu, W; Ma, T | 1 |
Hao, Y; Li, W; Pang, D; Xu, S; Zhang, X | 1 |
Abou-Aisha, K; Elsabbagh, RA; Gad, MZ; Rady, M; Watzl, C | 1 |
Chen, M; Du, X; Han, L; He, Y; Sun, J | 1 |
Chen, J; Chen, X; Chen, Y; Guo, A; Hu, C; Lin, C; Xu, H; Yang, J | 1 |
Hu, J; Li, P; Wang, ZY; Xu, Q; Zhang, CY | 1 |
Chang, X; Cheng, S; Duan, L; Gao, S; Gu, Y; Liu, T; Pan, Y; Xi, Y; Yang, F; Ye, Q; Zhang, Q; Zhu, X | 1 |
Ji, PZ; Liu, B; Ma, YC; Wu, PF; Xia, CM; Yang, YL; Zhu, LF; Zhu, M | 1 |
Jaffrey, SR; Ries, RJ; Zaccara, S | 1 |
Chen, C; Ji, X; Kan, Q; Liu, J; Ma, S; Sun, Z; Wang, G; Yuan, W; Zhou, Q | 1 |
He, L; Li, H; Peng, Y; Shu, G; Wu, A; Yin, G | 1 |
Gong, C; Hu, Y; Huang, Y; Liu, J; Wang, S; Xiao, Y; Yang, S | 1 |
Chen, J; Melstrom, L | 1 |
Haruehanroengra, P; Huang, Y; Sheng, J; Zheng, YY; Zhou, Y | 1 |
Chen, L; Chen, Z; Liu, YP; Sun, W; Tang, Q; Tian, LF; Wu, W; Yan, XX | 1 |
Shen, H; Shi, Y; Xie, W; Zhao, Y | 1 |
Deng, H; Kidwell, RL; Liang, Z; Xie, Q | 1 |
Deng, S; Li, R; Li, X; Lin, D; Liu, X; Ye, Y; Zhang, H; Zheng, J; Zhu, K; Zuo, Z | 1 |
Ju, S; Kong, S; Tao, M; Wang, T | 1 |
Choe, J; Han, SH | 1 |
Chen, Y; Gao, W; He, J; Lin, Y; Shu, Y | 1 |
Feng, D; Han, J; Lu, Q; Lv, J; Wu, Q; Yang, H; Yang, X; Yu, H; Yuan, B; Zhou, Z | 1 |
Deng, D; Liu, W; Tian, W; Xiang, M; You, A | 1 |
Chen, C; Guo, Y; Hou, C; Liu, J; Sun, Z; Yin, D; Yuan, W; Zhang, L | 1 |
Asada, K; Bolatkan, A; Hamamoto, R; Kaneko, S; Komatsu, M; Takasawa, K | 1 |
Chen, XY; Yi, YC; Zhang, J; Zhu, JS | 1 |
Huang, W; Li, Y; Weng, H; Zeng, C | 1 |
Assaraf, YG; Chen, ZS; Huang, C; Jiang, J; Li, B; Xiao, H | 1 |
Cai, Y; Gao, M; Gong, Z; Guo, G; Huang, J; Peng, B; Wu, G; Xu, Z; Yan, Y; Zeng, S | 1 |
Kumari, S; Muthusamy, S | 1 |
Huo, FC; Pei, DS; Zhu, ZM | 1 |
Barderas, R; Campuzano, S; Gamella, M; Montero-Calle, A; Navarro-Villoslada, F; Pedrero, M; Pingarrón, JM; Povedano, E; Solís-Fernández, G; Torrente-Rodríguez, RM | 1 |
Bao, Y; Gong, C; Hu, Y; Li, Z; Wang, S; Xiao, Y; Yang, C; Yang, H; Zhou, B | 1 |
Chen, J; He, Z; Ren, D; Tian, Y; Wang, L; Yan, X; Yuan, X; Zhang, Q; Zhang, T; Zhang, W | 1 |
Blanco, S; Miguel-López, B; Nombela, P | 1 |
Cui, X; Cui, Y; Ji, G; Xu, Z | 1 |
Li, M; Wang, S; Zha, X | 1 |
Bai, J; Cai, Y; Chang, Z; Li, D; Li, Y; Xu, J; Xu, K; Zhang, M; Zou, H | 1 |
Chen, R; Hou, G; Huang, C; Jiang, B; Li, L; Liu, X; Lu, R; Wang, Y; Yang, Q; Yu, J; Zhao, X | 1 |
Chen, Y; Duan, L; Jiang, X; Jin, Z; Liu, B; Nie, Z; Xiong, Q; Yang, C | 1 |
Liu, F; Su, X | 1 |
Paramasivam, A; Priyadharsini, JV | 1 |
Chen, F; Hu, Z; Jiang, Y; Li, Y; Lin, L; Liu, Z; Shen, H; Shen, S; Wei, Y; Zhang, R; Zhao, Y | 1 |
Gong, Z; Guo, C; He, Y; Li, G; Li, X; Li, Y; Shi, L; Tan, F; Wang, F; Wang, Y; Xiang, B; Xiong, F; Xiong, W; Zeng, Z; Zhang, S; Zhao, M; Zhou, M | 1 |
Li, Z; Lin, C; Lu, Y; Shen, Z; Zhang, J | 1 |
Barr, T; Caligiuri, MA; Chen, J; Chen, Z; Ma, S; Sun, JC; Wang, LS; Yan, J; Yu, J; Zhang, J | 1 |
Capell, BC; Maldonado López, A | 1 |
Bell, JL; Hüttelmaier, S; Lan, Q; Liu, PY; Liu, T; Wang, JY; Zhang, L; Zhang, XD | 1 |
Lv, Y; Tang, M | 1 |
Jia, G; Qian, Y; Zhang, W | 1 |
Guo, C; Li, Y; Liu, K; Ouyang, L; Zhang, C; Zhao, Q | 1 |
Chen, TQ; Chen, YQ; Fang, K; Huang, W; Ye, H; Zeng, ZC | 1 |
Gao, X; Han, B; Li, F; Li, Z; Wei, S; Zhang, J | 1 |
Duan, Y; Mao, Y; Qin, S; Wang, H; Zhao, L | 1 |
Li, H; Li, J; Ma, Z; Qiu, M; Sun, C; Wang, S; Xia, W; Xu, L; Xu, W; Xu, Y; Yin, R; Zhang, E | 1 |
Chen, J; Deng, X; Feng, X; Su, R; Wei, M | 1 |
He, C; Hsu, PJ; Shi, H | 1 |
Batista, PJ; Schmiechen, AC | 1 |
Fan, YG; Leng, RX; Li, LJ; Pan, HF; Ye, DQ | 1 |
Dai, D; Jin, H; Wang, H; Wang, X; Zhu, L | 1 |
Cui, YH; He, YY; Robinson, M; Shah, P | 1 |
Zhang, S | 1 |
Chang, G; Huang, S; Leu, JS; Ma, L; Xie, K | 1 |
Chai, P; Jia, R; Wang, S | 1 |
He, L; Li, J; Wang, X; Xie, H; Xie, L; Yan, H; Ying, Y; Zheng, X | 1 |
He, C; Li, Z; Liu, H; Luan, S; Luo, J | 1 |
Chen, J; Du, B | 1 |
Chen, Y; Fan, XN; Gao, SJ; Huang, Y; Meng, J; Zhang, SW; Zhang, SY | 1 |
Ming, L; Sun, T; Wu, R | 1 |
Chen, B; Li, Y; Song, R; Xu, F; Xue, C | 2 |
Kalkan, R; Tuncel, G | 1 |
Bell, JL; Haase, J; Hüttelmaier, S; Lan, Q; Liu, PY; Liu, T | 1 |
Harada, BT; He, C; Liu, J | 1 |
Cao, M; Guo, M; Hu, Q; Pan, C; Wang, JZ; Wei, JF; Xu, Z; Yang, H; Zhu, W | 1 |
Fu, J; Zhang, C; Zhou, Y | 1 |
Ishii, H; Konno, M; Taniguchi, M | 1 |
Lang, F; Pei, Y; Robertson, ES; Singh, RK; Sun, K; Zhang, S | 1 |
Das, B; Maity, A | 1 |
Jaffrey, SR; Kharas, MG | 1 |
Guo, X; Ji, S; Ji, X; Wei, W | 1 |
78 review(s) available for n-methyladenosine and Neoplasms
Article | Year |
---|---|
N
Topics: Adenosine; Animals; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasms; RNA, Neoplasm; Tumor Microenvironment | 2021 |
Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH.
Topics: Adenosine; Animals; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Molecular Targeted Therapy; Neoplasms; RNA Processing, Post-Transcriptional; Transcriptome | 2021 |
Insights into roles of METTL14 in tumors.
Topics: Adenosine; Animals; Genes, Tumor Suppressor; Humans; Methyltransferases; Neoplasms; Oncogenes; RNA | 2022 |
N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Topics: Adenosine; Animals; Humans; Immunotherapy; Methylation; Neoplasms; RNA; Tumor Microenvironment | 2021 |
The role of m6A RNA methylation in cancer metabolism.
Topics: Adenosine; Animals; Biomarkers; Disease Management; Disease Susceptibility; Energy Metabolism; Gene Expression Regulation, Neoplastic; Humans; Methylation; Mitochondria; Neoplasms; RNA; RNA Processing, Post-Transcriptional; RNA, Circular; RNA, Messenger; RNA, Untranslated; Signal Transduction; Transcription Factors | 2022 |
Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications.
Topics: Adenosine; Humans; Methylation; Neoplasms; RNA, Messenger | 2022 |
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Neoplasms; RNA; RNA Processing, Post-Transcriptional | 2022 |
Insights into N6-methyladenosine and programmed cell death in cancer.
Topics: Adenosine; Apoptosis; Humans; Methylation; Neoplasms | 2022 |
N6-methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis.
Topics: Adenosine; Animals; Carcinogenesis; Cell Transformation, Neoplastic; Humans; Immunity; Inflammation; Neoplasms; Tumor Microenvironment | 2022 |
The emerging roles of the interaction between m6A modification and c-Myc in driving tumorigenesis and development.
Topics: Adenosine; Carcinogenesis; Gene Expression Regulation; Humans; Neoplasms; Proto-Oncogene Proteins c-myc | 2022 |
Role of main RNA modifications in cancer: N
Topics: 5-Methylcytosine; Adenosine; Humans; Neoplasms; Pseudouridine; RNA Processing, Post-Transcriptional; RNA, Untranslated | 2022 |
Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.
Topics: Adenosine; Disease Progression; Humans; Neoplasms; RNA; RNA-Binding Proteins; Transcription Factors | 2022 |
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Topics: Adenosine; Drug Resistance, Neoplasm; Humans; Methylation; Neoplasms; RNA, Circular | 2022 |
Multifaceted Roles of the
Topics: Adenosine; Humans; Methyltransferases; Neoplasms; RNA, Messenger; Tumor Microenvironment | 2022 |
Targeting RNA N
Topics: Adenosine; Humans; Immunotherapy; Neoplasms; RNA; Tumor Escape | 2022 |
Impact of N6-methyladenosine (m
Topics: Adenosine; Humans; Methylation; Methyltransferases; Neoplasms | 2022 |
Novel insight into the functions of N
Topics: Biomarkers; Humans; Neoplasms; RNA Precursors; RNA, Long Noncoding; Tumor Microenvironment | 2022 |
The Role of N
Topics: Adenosine; Epigenesis, Genetic; Humans; Neoplasms; RNA | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Reading, writing and erasing mRNA methylation.
Topics: Adenosine; Animals; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Neoplasm | 2019 |
The interplay between m6A RNA methylation and noncoding RNA in cancer.
Topics: Adenosine; Humans; Methylation; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Neoplasm; RNA, Untranslated | 2019 |
Functions of N6-methyladenosine and its role in cancer.
Topics: Adenosine; Animals; Biomarkers; Disease Susceptibility; Gene Expression Regulation, Neoplastic; Humans; Methylation; Molecular Targeted Therapy; Neoplasms; Protein Binding; RNA, Messenger; Signal Transduction | 2019 |
New sights in cancer: Component and function of N6-methyladenosine modification.
Topics: Adenosine; Animals; Epigenesis, Genetic; Humans; Methylation; Neoplasms; RNA; RNA, Messenger | 2020 |
RNA N
Topics: Adenosine; Epigenesis, Genetic; Humans; Neoplasms; RNA | 2020 |
RNA modifications and cancer.
Topics: Adenosine; Animals; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; RNA; RNA Processing, Post-Transcriptional; RNA, Long Noncoding; RNA, Messenger; RNA, Ribosomal; RNA, Transfer; Transcriptome | 2020 |
m
Topics: Adenosine; Animals; Epigenesis, Genetic; Hematopoiesis; Humans; Neoplasms; Protein Binding; Proteins; RNA Processing, Post-Transcriptional; RNA, Messenger; Virus Diseases; Virus Physiological Phenomena; Viruses | 2020 |
Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Topics: Adenosine; Antineoplastic Agents; Carcinogenesis; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Neoplasms; Oxidoreductases, N-Demethylating; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA-Binding Proteins | 2020 |
The potential role of RNA N6-methyladenosine in Cancer progression.
Topics: Adenosine; Animals; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms | 2020 |
Diverse molecular functions of m
Topics: Adenosine; Alternative Splicing; Animals; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; Nucleic Acid Conformation; Organ Specificity; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Structure-Activity Relationship | 2020 |
Interaction between N
Topics: Adenosine; Animals; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms; RNA, Untranslated | 2020 |
Mechanism of RNA modification N6-methyladenosine in human cancer.
Topics: Adenosine; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms | 2020 |
The role of N
Topics: Adenosine; Animals; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Neoplasms; RNA, Circular | 2020 |
Critical Roles of
Topics: Adenosine; Animals; Epigenesis, Genetic; Humans; Neoplasms; RNA; RNA Folding; RNA Processing, Post-Transcriptional; RNA Stability; RNA Transport; Virus Diseases | 2020 |
Novel insights into the interplay between m
Topics: Adenosine; Animals; Carcinogenesis; Disease Susceptibility; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Methylation; MicroRNAs; Neoplasms; RNA Interference; RNA, Circular; RNA, Long Noncoding; RNA, Messenger; RNA, Untranslated | 2020 |
Roles of METTL3 in cancer: mechanisms and therapeutic targeting.
Topics: Adenosine; Antineoplastic Agents; Binding, Competitive; Carcinogens; Drug Design; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Methylation; Methyltransferases; Models, Molecular; Molecular Targeted Therapy; Neoplasm Proteins; Neoplasms; Oncogenes; Protein Conformation; Protein Domains; Recombinant Fusion Proteins; RNA Processing, Post-Transcriptional; RNA, Neoplasm; Substrate Specificity; Tumor Suppressor Proteins | 2020 |
Surmounting cancer drug resistance: New insights from the perspective of N
Topics: Adenosine; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Disease Models, Animal; DNA Damage; DNA Repair; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Methylation; Neoplasms; Protein Kinase Inhibitors; RNA Processing, Post-Transcriptional; Treatment Outcome; Tumor Microenvironment | 2020 |
N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
Topics: Adenosine; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Neoplasms; RNA | 2020 |
SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer.
Topics: Adenosine; Biomarkers, Tumor; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Humans; Mutation; Neoplasms; Prognosis | 2020 |
N
Topics: Adenosine; Animals; Disease Progression; Humans; Methylation; Methyltransferases; Neoplasms; RNA, Messenger | 2020 |
The role of m
Topics: Adenosine; Animals; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation; Humans; Mental Disorders; Metabolic Diseases; Neoplasms; RNA, Messenger | 2020 |
Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Topics: Adenosine; Bone and Bones; Cartilage; Humans; Methylation; MicroRNAs; Neoplasms; RNA; RNA, Long Noncoding; RNA, Messenger | 2021 |
The role of m
Topics: 5-Methylcytosine; Adenosine; Humans; Neoplasms; Pseudouridine; RNA; RNA Processing, Post-Transcriptional | 2021 |
The Impacts of Non-coding RNAs and N
Topics: Adenosine; Cell Differentiation; Drug Discovery; Gene Regulatory Networks; Humans; Neoplasms; RNA, Untranslated | 2021 |
The role of N6-methyladenosine mRNA in the tumor microenvironment.
Topics: Adenosine; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplastic Stem Cells; RNA, Messenger; Tumor Microenvironment | 2021 |
The role of m6A modification in the biological functions and diseases.
Topics: Adenosine; Epigenesis, Genetic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Methylation; Methyltransferases; Neoplasms; Nerve Tissue Proteins; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA-Binding Proteins | 2021 |
Effects of m6A modifications on signaling pathways in human cancer (Review).
Topics: Adenosine; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; RNA Processing, Post-Transcriptional; Signal Transduction | 2021 |
N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies.
Topics: Adenosine; Disease Progression; Humans; Neoplasms; Signal Transduction | 2021 |
Translation role of circRNAs in cancers.
Topics: Adenosine; Animals; Humans; Models, Biological; Neoplasms; RNA Caps; RNA, Circular; Translational Research, Biomedical | 2021 |
The METTL3-m
Topics: Adenosine; Cell Differentiation; Epigenesis, Genetic; Epithelial Cells; Gene Expression Regulation; Humans; Methyltransferases; Neoplasms; Transcriptome | 2021 |
The Emerging Roles of RNA m
Topics: Adenosine; Animals; Demethylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; RNA | 2021 |
The Role of
Topics: Adenosine; Animals; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; RNA, Circular | 2021 |
The detection and functions of RNA modification m
Topics: Adenosine; Eukaryotic Cells; Humans; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger | 2021 |
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Topics: Adenosine; Animals; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Molecular Targeted Therapy; Neoplasms; Signal Transduction | 2021 |
Decoding m
Topics: Adenosine; Animals; Gene Expression; Humans; Methylation; Neoplasms; Protein Domains; RNA Processing, Post-Transcriptional; RNA, Messenger | 2021 |
The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Topics: Adenosine; Animals; Biomarkers, Tumor; Humans; Molecular Targeted Therapy; Neoplasms; RNA, Untranslated; Signal Transduction | 2021 |
Roles of RNA methylation by means of N
Topics: Adenosine; Gene Expression Regulation; Humans; Methylation; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional | 2017 |
Role of N
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Gene Expression Regulation, Neoplastic; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger | 2018 |
Epitranscriptomic influences on development and disease.
Topics: Adenosine; Animals; Cell Differentiation; Growth and Development; Humans; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Transfer; Transcriptome | 2017 |
Potential link between m
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Epigenesis, Genetic; Gene Expression Regulation; HIV Infections; Humans; Lupus Erythematosus, Systemic; Methyltransferases; Neoplasms; Nucleic Acid Conformation; Protein Biosynthesis; RNA Precursors; RNA Processing, Post-Transcriptional; RNA Splicing; RNA Stability; RNA-Binding Proteins | 2018 |
N6-methyladenosine links RNA metabolism to cancer progression.
Topics: Adenosine; Animals; Disease Progression; DNA Damage; Humans; Neoplasms; RNA, Long Noncoding; RNA, Neoplasm | 2018 |
The Role of Dynamic m
Topics: Adenosine; Circadian Clocks; DNA Damage; DNA Repair; Humans; Methylation; Neoplasms; RNA; Stem Cells; Ultraviolet Rays | 2019 |
Mechanism of N
Topics: Adenosine; Animals; Histone Demethylases; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA Editing | 2018 |
Methylation of RNA N
Topics: Adenosine; Animals; Carcinogenesis; Cytokines; Humans; Methylation; Neoplasms; RNA | 2019 |
Novel insights on m
Topics: Adenosine; Carcinogenesis; Disease Progression; Gene Regulatory Networks; Humans; Neoplasms; RNA, Messenger | 2018 |
The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinogenesis; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Methylation; Methyltransferases; Molecular Targeted Therapy; Neoplasms; RNA Editing; RNA, Neoplasm | 2018 |
Aberrant Regulation of mRNA m⁶A Modification in Cancer Development.
Topics: Adenosine; Animals; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Methylation; Methyltransferases; Neoplasms; RNA, Messenger | 2018 |
Novel positioning from obesity to cancer: FTO, an m
Topics: 3' Untranslated Regions; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Body Mass Index; Cell Proliferation; Demethylation; Disease Progression; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation; Humans; Neoplasm Metastasis; Neoplasms; Obesity; Oncogenes; Polymorphism, Single Nucleotide; Prognosis; Radiation Tolerance | 2019 |
The role of m6A RNA methylation in cancer.
Topics: Adenosine; Animals; Humans; Methylation; Neoplasms; RNA | 2019 |
Functions of RNA N6-methyladenosine modification in cancer progression.
Topics: Adenosine; Animals; Disease Progression; Humans; Methylation; Neoplasms; RNA | 2019 |
Importance of m N
Topics: Adenosine; Animals; DNA Damage; Humans; Methylation; Neoplasms; RNA, Neoplasm | 2019 |
The Critical Role of RNA m
Topics: Adenosine; Demethylation; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA-Binding Proteins | 2019 |
Functions of RNA N6-methyladenosine modification in cancer progression.
Topics: Adenosine; Disease Progression; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA Processing, Post-Transcriptional | 2019 |
Regulation of Gene Expression by N
Topics: Adenosine; Animals; Gene Expression Regulation, Neoplastic; Humans; Neoplasms | 2019 |
Detection of N6‑methyladenosine modification residues (Review).
Topics: Adenosine; Animals; Biosensing Techniques; Blotting, Northern; Chromatography, High Pressure Liquid; Electrochemical Techniques; Humans; Immunoblotting; Immunoprecipitation; Methylation; Neoplasms; RNA; Sequence Analysis, RNA | 2019 |
A Review in Research Progress Concerning m6A Methylation and Immunoregulation.
Topics: Active Transport, Cell Nucleus; Adenosine; Humans; Methylation; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional; RNA Splicing; RNA, Messenger | 2019 |
Significant epitranscriptomes in heterogeneous cancer.
Topics: Adenosine; Animals; Eukaryota; Humans; Neoplasms; Precision Medicine; RNA, Messenger; Transcriptome | 2019 |
N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
Topics: Adenosine; Cell Differentiation; Eukaryotic Cells; Humans; Methylation; Methyltransferases; Neoplasms; Neurodegenerative Diseases; Oxidoreductases, N-Demethylating; RNA Splicing; RNA, Long Noncoding; RNA, Messenger; Signal Transduction; Transcription, Genetic | 2016 |
Regulatory Role of N
Topics: Adenosine; Animals; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Methylation; Neoplasms; Obesity; RNA Processing, Post-Transcriptional; RNA, Neoplasm | 2017 |
1 trial(s) available for n-methyladenosine and Neoplasms
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
23 other study(ies) available for n-methyladenosine and Neoplasms
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
METTL3-mediated m
Topics: Adenosine; Animals; Carcinogenesis; Cell Line, Tumor; Gene Deletion; Homeostasis; Interleukin-15; Killer Cells, Natural; Lymphocytes, Tumor-Infiltrating; Methylation; Methyltransferases; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; RNA; Signal Transduction; Tumor Microenvironment | 2021 |
m
Topics: Adenosine; Biomarkers, Tumor; Circulating MicroRNA; Computational Biology; Diagnosis, Differential; Gene Expression Profiling; Humans; Liquid Biopsy; MicroRNAs; Neoplasms; Prognosis; Reproducibility of Results; ROC Curve | 2021 |
The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells.
Topics: Adenosine; Adipose Tissue; Adiposity; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Catalysis; Disease Susceptibility; Epigenesis, Genetic; Gene Expression Regulation; Homeostasis; Humans; Neoplasms; Organ Specificity; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Messenger; RNA, Small Nuclear; RNA, Transfer; Substrate Specificity | 2022 |
Bibliometric analysis of N6-methyladenosine in cancer: landscapes, highlights and trending topics.
Topics: Adenosine; Bibliometrics; China; Humans; Neoplasms | 2022 |
FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Autophagy-Related Protein 5; Endometriosis; Female; Humans; Neoplasms; RNA, Messenger | 2022 |
Construction of a Single-Molecule Biosensor for Antibody-Free Detection of Locus-Specific
Topics: Biosensing Techniques; Humans; Limit of Detection; Neoplasms | 2023 |
Epitranscriptic regulation of
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinogenesis; Cell Transformation, Neoplastic; Humans; Neoplasms; Proto-Oncogene Proteins p21(ras); Signal Transduction; Transcription, Genetic | 2023 |
[Research progress in the regulation of tumor cell PD-L1 expression by N6-methyladenosine modification].
Topics: B7-H1 Antigen; Humans; Neoplasms | 2023 |
Structural basis of nucleic acid recognition and 6mA demethylation by human ALKBH1.
Topics: Adenosine; AlkB Homolog 1, Histone H2a Dioxygenase; DNA; DNA Demethylation; Humans; Neoplasms; Protein Binding; Protein Structural Elements | 2020 |
M6A2Target: a comprehensive database for targets of m6A writers, erasers and readers.
Topics: Adenosine; Databases, Genetic; Humans; Mutation; Neoplasms; Reproducibility of Results | 2021 |
RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Cell Cycle Proteins; Drug Resistance, Neoplasm; Humans; Methylation; Methyltransferases; Neoplasms; Radiation Tolerance; RNA; RNA Splicing Factors | 2020 |
Magnetic microbeads-based amperometric immunoplatform for the rapid and sensitive detection of N6-methyladenosine to assist in metastatic cancer cells discrimination.
Topics: Adenosine; Biosensing Techniques; Hydrogen Peroxide; Limit of Detection; Magnetic Phenomena; Microspheres; Neoplasms | 2021 |
Pan-cancer characterization of expression and clinical relevance of m
Topics: Adenosine; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Methylation; Neoplasm Staging; Neoplasms; Organ Specificity; Prognosis; RNA, Long Noncoding | 2021 |
SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Topics: Adenosine; Animals; Cell Hypoxia; Cell Line; Disease Progression; Humans; Lysine; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oxidative Stress; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Transcriptome; Ubiquitination | 2021 |
RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance.
Topics: Adenosine; Autophagy; Disease Progression; Drug Resistance, Neoplasm; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA Processing, Post-Transcriptional | 2021 |
Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types.
Topics: Adenosine; Biomarkers, Tumor; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; Organ Specificity; RNA, Messenger; RNA, Untranslated | 2021 |
The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.
Topics: Adenosine; Animals; Antiviral Agents; Cell Proliferation; Cell Survival; Cytomegalovirus Infections; Disease Progression; DNA-Binding Proteins; Homeostasis; Immunity; Interleukin-15; Killer Cells, Natural; Mice, Inbred C57BL; Neoplasms; RNA; RNA-Binding Proteins; Transcriptome | 2021 |
The role of YTH domain containing 2 in epigenetic modification and immune infiltration of pan-cancer.
Topics: Adenosine; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Prognosis; RNA Helicases | 2021 |
An epitranscriptomic vulnerability in myeloid malignancies.
Topics: Adenosine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Methyltransferases; Myeloproliferative Disorders; Neoplasms | 2017 |
Global analysis of N6-methyladenosine functions and its disease association using deep learning and network-based methods.
Topics: Adenosine; Algorithms; Computational Biology; Deep Learning; Genetic Markers; Humans; Neoplasms; Protein Interaction Maps; Software | 2019 |
EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis.
Topics: Adenosine; Animals; Cell Line, Tumor; Cell Transformation, Viral; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; HEK293 Cells; Herpesvirus 4, Human; Humans; Male; Methyltransferases; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Neoplasms | 2019 |
Emerging links between m
Topics: Adenosine; Animals; Humans; Methylation; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger | 2017 |